Patricia G. Moorman

13.5k total citations · 3 hit papers
135 papers, 8.7k citations indexed

About

Patricia G. Moorman is a scholar working on Oncology, Reproductive Medicine and Genetics. According to data from OpenAlex, Patricia G. Moorman has authored 135 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 52 papers in Reproductive Medicine and 49 papers in Genetics. Recurrent topics in Patricia G. Moorman's work include Cancer Risks and Factors (48 papers), Ovarian cancer diagnosis and treatment (46 papers) and BRCA gene mutations in cancer (27 papers). Patricia G. Moorman is often cited by papers focused on Cancer Risks and Factors (48 papers), Ovarian cancer diagnosis and treatment (46 papers) and BRCA gene mutations in cancer (27 papers). Patricia G. Moorman collaborates with scholars based in United States, Australia and China. Patricia G. Moorman's co-authors include Robert C. Millikan, Joseph Geradts, Beth Newman, Lisa A. Carey, Charles M. Perou, Chad Livasy, H. Shelton Earp, Kathleen Conway, Barbara S. Hulka and Chiu Kit Tse and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patricia G. Moorman

134 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

2006 3.0k citations Lisa A. Carey, Charles M. Perou et al. JAMA profile →
Epidemiology of basal-like breast cancer

2007 691 citations Robert C. Millikan, Patricia G. Moorman et al. profile →
Benefits and Harms of Breast Cancer Screening

2015 430 citations Evan R. Myers, Patricia G. Moorman et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia G. Moorman United States	41	4.8k	3.3k	2.0k	1.7k	1.2k	135	8.7k
R. Kreienberg Germany	54	4.3k 0.9×	3.4k 1.0×	934 0.5×	2.1k 1.2×	1.5k 1.3×	434	10.6k
Steinar Tretli Norway	64	4.8k 1.0×	2.1k 0.6×	1.3k 0.6×	2.6k 1.5×	999 0.8×	243	11.4k
Ping Sun Canada	47	4.9k 1.0×	4.4k 1.3×	4.2k 2.1×	2.8k 1.7×	1.6k 1.3×	128	10.9k
Kathleen E. Malone United States	63	7.2k 1.5×	4.0k 1.2×	3.9k 2.0×	2.7k 1.6×	657 0.5×	221	12.3k
Michael S. Simon United States	49	3.8k 0.8×	1.9k 0.6×	2.0k 1.0×	1.2k 0.7×	398 0.3×	261	7.7k
Lucia Del Mastro Italy	48	5.3k 1.1×	2.5k 0.8×	1.6k 0.8×	1.2k 0.7×	1.3k 1.1×	332	8.7k
Walter M. Cronin United States	19	3.6k 0.8×	3.3k 1.0×	4.6k 2.3×	1.2k 0.7×	549 0.5×	31	8.5k
Saundra S. Buys United States	36	2.1k 0.4×	1.4k 0.4×	1.8k 0.9×	1.5k 0.9×	1.5k 1.2×	137	6.1k
Andrea Eisen Canada	49	3.1k 0.6×	2.9k 0.9×	4.9k 2.4×	1.6k 0.9×	1.1k 0.9×	189	8.3k
Parviz Ghadirian Canada	51	2.1k 0.4×	1.8k 0.6×	4.0k 2.0×	1.8k 1.0×	1.3k 1.0×	131	8.2k

Countries citing papers authored by Patricia G. Moorman

Since Specialization

Citations

This map shows the geographic impact of Patricia G. Moorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia G. Moorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia G. Moorman more than expected).

Fields of papers citing papers by Patricia G. Moorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia G. Moorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia G. Moorman. The network helps show where Patricia G. Moorman may publish in the future.

Co-authorship network of co-authors of Patricia G. Moorman

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia G. Moorman. A scholar is included among the top collaborators of Patricia G. Moorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia G. Moorman. Patricia G. Moorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harris, Holly R., Lauren C. Peres, Courtney E. Johnson, et al.. (2023). Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. Obstetrics and Gynecology. 141(6). 1124–1138. 7 indexed citations

Petrick, Jessica L., Charlotte E. Joslin, Courtney E. Johnson, et al.. (2023). Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium. British Journal of Cancer. 129(12). 1956–1967. 3 indexed citations

Harris, Holly R., Kristin A. Guertin, Courtney E. Johnson, et al.. (2022). Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium. International Journal of Cancer. 151(8). 1228–1239. 12 indexed citations

Nash, Rebecca, Courtney E. Johnson, Holly R. Harris, et al.. (2022). Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1610–1620. 1 indexed citations

Ochs‐Balcom, Heather M., Courtney E. Johnson, Kristin A. Guertin, et al.. (2022). Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium. British Journal of Cancer. 127(11). 1983–1990. 1 indexed citations

Bandera, Elisa V., Traci N. Bethea, Fabian Camacho, et al.. (2021). Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer Epidemiology Biomarkers & Prevention. 30(9). 1660–1668. 5 indexed citations

Wang, Tengteng, Hazel B. Nichols, Sarah J. Nyante, et al.. (2020). Urinary Estrogen Metabolites and Long-Term Mortality Following Breast Cancer. JNCI Cancer Spectrum. 4(3). pkaa014–pkaa014. 2 indexed citations

Zhao, Lingling, Hongliang Liu, Sheng Luo, et al.. (2020). Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk. Cancer Medicine. 9(24). 9620–9631. 1 indexed citations

Wang, Tengteng, Patrick T. Bradshaw, Patricia G. Moorman, et al.. (2020). Menopausal hormone therapy use and long‐term all‐cause and cause‐specific mortality in the Long Island Breast Cancer Study Project. International Journal of Cancer. 147(12). 3404–3415. 5 indexed citations

10.

Anderson, Roger T., Lauren C. Peres, Fabian Camacho, et al.. (2018). Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study. Journal of Women s Health. 28(2). 284–293. 13 indexed citations

11.

Moorman, Patricia G., Nadine J. Barrett, Frances Wang, et al.. (2018). Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women. Journal of Women s Health. 28(4). 444–451. 15 indexed citations

12.

DeBono, Nathan, Whitney R. Robinson, Jennifer L. Lund, et al.. (2017). Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. Journal of Women s Health. 27(3). 377–386. 6 indexed citations

13.

Terry, Paul, Bo Qin, Fabian Camacho, et al.. (2017). Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women. Journal of Nutrition. 147(4). 621–627. 18 indexed citations

14.

Gierisch, Jennifer M., Remy R Coeytaux, Rachel Peragallo Urrutia, et al.. (2013). Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review. Cancer Epidemiology Biomarkers & Prevention. 22(11). 1931–1943. 236 indexed citations

15.

Allott, Emma H., Michael R. Abern, Lukas C. Gerber, et al.. (2013). Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer and Prostatic Diseases. 16(4). 391–397. 46 indexed citations

16.

Moorman, Patricia G., Phyllis C. Leppert, Evan R. Myers, & Frances Wang. (2012). Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy. Fertility and Sterility. 99(3). 768–776.e1. 30 indexed citations

17.

Moorman, Patricia G., et al.. (2009). Southeast Raleigh Minority Faith-based Health Promotion Initiative. Californian Journal of Health Promotion. 7(SI). 87–98. 3 indexed citations

18.

Carey, Lisa A., Charles M. Perou, Chad Livasy, et al.. (2006). Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA. 295(21). 2492–2492. 2986 indexed citations breakdown →

19.

Moorman, Patricia G., Andrew Berchuck, Brian Calingaert, Susan Halabi, & Joellen M. Schildkraut. (2005). Antidepressant Medication Use for and Risk of Ovarian Cancer. Obstetrics and Gynecology. 105(4). 725–730. 21 indexed citations

20.

Marcus, Pamela M., et al.. (1999). Adolescent reproductive events and subsequent breast cancer risk.. American Journal of Public Health. 89(8). 1244–1247. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact